Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3091927
Max Phase: Preclinical
Molecular Formula: C35H44Cl2N6O3S3
Molecular Weight: 728.43
Molecule Type: Small molecule
Associated Items:
ID: ALA3091927
Max Phase: Preclinical
Molecular Formula: C35H44Cl2N6O3S3
Molecular Weight: 728.43
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCn1c(=O)/c(=C2\Sc3c(Cl)cccc3N2C)s/c1=C\c1cccc[n+]1CCCCCCNC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@@H]21.[Cl-]
Standard InChI: InChI=1S/C35H43ClN6O3S3.ClH/c1-3-42-29(47-32(33(42)44)34-40(2)26-15-12-14-24(36)31(26)48-34)21-23-13-8-11-20-41(23)19-10-5-4-9-18-37-28(43)17-7-6-16-27-30-25(22-46-27)38-35(45)39-30;/h8,11-15,20-21,25,27,30H,3-7,9-10,16-19,22H2,1-2H3,(H2-,37,38,39,43,45);1H/b34-32+;/t25-,27-,30-;/m0./s1
Standard InChI Key: LUTBTJDALGRTQX-XMUWYNGYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 728.43 | Molecular Weight (Monoisotopic): 727.2320 | AlogP: 4.41 | #Rotatable Bonds: 14 |
Polar Surface Area: 99.35 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 3 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 13.49 | CX Basic pKa: | CX LogP: 1.55 | CX LogD: 1.55 |
Aromatic Rings: 3 | Heavy Atoms: 48 | QED Weighted: 0.13 | Np Likeness Score: -0.70 |
1. Li X, Srinivasan SR, Connarn J, Ahmad A, Young ZT, Kabza AM, Zuiderweg ER, Sun D, Gestwicki JE.. (2013) Analogs of the Allosteric Heat Shock Protein 70 (Hsp70) Inhibitor, MKT-077, as Anti-Cancer Agents., 4 (11): [PMID:24312699] [10.1021/ml400204n] |
Source(1):